NKX2.2, PDX-1 and CDX-2 as potential biomarkers to differentiate well-differentiated neuroendocrine tumors

• Hauptverfasser: Michelle X. Yang (Verfasst von), Ryan F. Coates (Verfasst von), Abiy Ambaye (Verfasst von), Valerie Cortright (Verfasst von), Jeannette M. Mitchell (Verfasst von), Alexa M. Buskey (Verfasst von), Richard Zubarik (Verfasst von), James G. Liu (Verfasst von), Steven Ades (Verfasst von), Maura M. Barry (Verfasst von)
• Format: Buch
• Veröffentlicht: BMC, 2018-04-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Abstract Background Well-differentiated neuroendocrine tumors (NET) most frequently arise from the gastrointestinal tract (GI), pancreas, and lung. Patients often present as metastasis with an unknown primary, and the clinical management and outcome depend on multiple factors, including the accurate...